BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study
Aims/hypothesis Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type...
Uloženo v:
| Vydáno v: | Diabetologia Ročník 64; číslo 4; s. 814 - 825 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.04.2021
Springer Nature B.V Springer Verlag |
| Témata: | |
| ISSN: | 0012-186X, 1432-0428, 1432-0428 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Aims/hypothesis
Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type 2 diabetes remains unresolved. We investigated the association between BMI and BMI change with long-term risk of microvascular and macrovascular complications in type 2 diabetes in a prospective cohort study.
Methods
We studied participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort, who were free of cancer, cardiovascular disease and microvascular disease at diagnosis (
n
= 1083). Pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI were evaluated in multivariable-adjusted Cox models.
Results
There were 85 macrovascular (myocardial infarction and stroke) and 347 microvascular events (kidney disease, neuropathy and retinopathy) over a median follow-up of 10.8 years. Median pre-diagnosis BMI was 29.9 kg/m
2
(IQR 27.4–33.2), and the median relative annual BMI change was −0.4% (IQR −2.1 to 0.9). Higher pre-diagnosis BMI was positively associated with total microvascular complications (multivariable-adjusted HR per 5 kg/m
2
[95% CI]: 1.21 [1.07, 1.36], kidney disease 1.39 [1.21, 1.60] and neuropathy 1.12 [0.96, 1.31]) but not with macrovascular complications (HR 1.05 [95% CI 0.81, 1.36]). Analyses according to BMI categories corroborated these findings. Effect modification was not evident by sex, smoking status or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62 [95% CI 0.47, 0.80]), kidney disease (HR 0.57 [95% CI 0.40, 0.81]) and neuropathy (HR 0.73 [95% CI 0.52, 1.03]), compared with participants with a stable BMI; no clear association was observed for macrovascular complications (HR 1.04 [95% CI 0.62, 1.74]). The associations between BMI gain compared with stable BMI and diabetes-related vascular complications were less apparent. Associations were consistent across strata of sex, age, pre-diagnosis BMI or medication but appeared to be stronger among never-smokers compared with current or former smokers.
Conclusions/interpretation
Among people with incident type 2 diabetes, pre-diagnosis BMI was positively associated with microvascular complications, while a reduced risk was observed with weight loss when compared with stable weight. The relationships with macrovascular disease were less clear.
Graphical abstract |
|---|---|
| AbstractList | Aims/hypothesisStudies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type 2 diabetes remains unresolved. We investigated the association between BMI and BMI change with long-term risk of microvascular and macrovascular complications in type 2 diabetes in a prospective cohort study.MethodsWe studied participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort, who were free of cancer, cardiovascular disease and microvascular disease at diagnosis (n = 1083). Pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI were evaluated in multivariable-adjusted Cox models.ResultsThere were 85 macrovascular (myocardial infarction and stroke) and 347 microvascular events (kidney disease, neuropathy and retinopathy) over a median follow-up of 10.8 years. Median pre-diagnosis BMI was 29.9 kg/m2 (IQR 27.4–33.2), and the median relative annual BMI change was −0.4% (IQR −2.1 to 0.9). Higher pre-diagnosis BMI was positively associated with total microvascular complications (multivariable-adjusted HR per 5 kg/m2 [95% CI]: 1.21 [1.07, 1.36], kidney disease 1.39 [1.21, 1.60] and neuropathy 1.12 [0.96, 1.31]) but not with macrovascular complications (HR 1.05 [95% CI 0.81, 1.36]). Analyses according to BMI categories corroborated these findings. Effect modification was not evident by sex, smoking status or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62 [95% CI 0.47, 0.80]), kidney disease (HR 0.57 [95% CI 0.40, 0.81]) and neuropathy (HR 0.73 [95% CI 0.52, 1.03]), compared with participants with a stable BMI; no clear association was observed for macrovascular complications (HR 1.04 [95% CI 0.62, 1.74]). The associations between BMI gain compared with stable BMI and diabetes-related vascular complications were less apparent. Associations were consistent across strata of sex, age, pre-diagnosis BMI or medication but appeared to be stronger among never-smokers compared with current or former smokers.Conclusions/interpretationAmong people with incident type 2 diabetes, pre-diagnosis BMI was positively associated with microvascular complications, while a reduced risk was observed with weight loss when compared with stable weight. The relationships with macrovascular disease were less clear. Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type 2 diabetes remains unresolved. We investigated the association between BMI and BMI change with long-term risk of microvascular and macrovascular complications in type 2 diabetes in a prospective cohort study.AIMS/HYPOTHESISStudies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type 2 diabetes remains unresolved. We investigated the association between BMI and BMI change with long-term risk of microvascular and macrovascular complications in type 2 diabetes in a prospective cohort study.We studied participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort, who were free of cancer, cardiovascular disease and microvascular disease at diagnosis (n = 1083). Pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI were evaluated in multivariable-adjusted Cox models.METHODSWe studied participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort, who were free of cancer, cardiovascular disease and microvascular disease at diagnosis (n = 1083). Pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI were evaluated in multivariable-adjusted Cox models.There were 85 macrovascular (myocardial infarction and stroke) and 347 microvascular events (kidney disease, neuropathy and retinopathy) over a median follow-up of 10.8 years. Median pre-diagnosis BMI was 29.9 kg/m2 (IQR 27.4-33.2), and the median relative annual BMI change was -0.4% (IQR -2.1 to 0.9). Higher pre-diagnosis BMI was positively associated with total microvascular complications (multivariable-adjusted HR per 5 kg/m2 [95% CI]: 1.21 [1.07, 1.36], kidney disease 1.39 [1.21, 1.60] and neuropathy 1.12 [0.96, 1.31]) but not with macrovascular complications (HR 1.05 [95% CI 0.81, 1.36]). Analyses according to BMI categories corroborated these findings. Effect modification was not evident by sex, smoking status or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62 [95% CI 0.47, 0.80]), kidney disease (HR 0.57 [95% CI 0.40, 0.81]) and neuropathy (HR 0.73 [95% CI 0.52, 1.03]), compared with participants with a stable BMI; no clear association was observed for macrovascular complications (HR 1.04 [95% CI 0.62, 1.74]). The associations between BMI gain compared with stable BMI and diabetes-related vascular complications were less apparent. Associations were consistent across strata of sex, age, pre-diagnosis BMI or medication but appeared to be stronger among never-smokers compared with current or former smokers.RESULTSThere were 85 macrovascular (myocardial infarction and stroke) and 347 microvascular events (kidney disease, neuropathy and retinopathy) over a median follow-up of 10.8 years. Median pre-diagnosis BMI was 29.9 kg/m2 (IQR 27.4-33.2), and the median relative annual BMI change was -0.4% (IQR -2.1 to 0.9). Higher pre-diagnosis BMI was positively associated with total microvascular complications (multivariable-adjusted HR per 5 kg/m2 [95% CI]: 1.21 [1.07, 1.36], kidney disease 1.39 [1.21, 1.60] and neuropathy 1.12 [0.96, 1.31]) but not with macrovascular complications (HR 1.05 [95% CI 0.81, 1.36]). Analyses according to BMI categories corroborated these findings. Effect modification was not evident by sex, smoking status or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62 [95% CI 0.47, 0.80]), kidney disease (HR 0.57 [95% CI 0.40, 0.81]) and neuropathy (HR 0.73 [95% CI 0.52, 1.03]), compared with participants with a stable BMI; no clear association was observed for macrovascular complications (HR 1.04 [95% CI 0.62, 1.74]). The associations between BMI gain compared with stable BMI and diabetes-related vascular complications were less apparent. Associations were consistent across strata of sex, age, pre-diagnosis BMI or medication but appeared to be stronger among never-smokers compared with current or former smokers.Among people with incident type 2 diabetes, pre-diagnosis BMI was positively associated with microvascular complications, while a reduced risk was observed with weight loss when compared with stable weight. The relationships with macrovascular disease were less clear.CONCLUSIONS/INTERPRETATIONAmong people with incident type 2 diabetes, pre-diagnosis BMI was positively associated with microvascular complications, while a reduced risk was observed with weight loss when compared with stable weight. The relationships with macrovascular disease were less clear. Aims/hypothesis Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type 2 diabetes remains unresolved. We investigated the association between BMI and BMI change with long-term risk of microvascular and macrovascular complications in type 2 diabetes in a prospective cohort study. Methods We studied participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort, who were free of cancer, cardiovascular disease and microvascular disease at diagnosis ( n = 1083). Pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI were evaluated in multivariable-adjusted Cox models. Results There were 85 macrovascular (myocardial infarction and stroke) and 347 microvascular events (kidney disease, neuropathy and retinopathy) over a median follow-up of 10.8 years. Median pre-diagnosis BMI was 29.9 kg/m 2 (IQR 27.4–33.2), and the median relative annual BMI change was −0.4% (IQR −2.1 to 0.9). Higher pre-diagnosis BMI was positively associated with total microvascular complications (multivariable-adjusted HR per 5 kg/m 2 [95% CI]: 1.21 [1.07, 1.36], kidney disease 1.39 [1.21, 1.60] and neuropathy 1.12 [0.96, 1.31]) but not with macrovascular complications (HR 1.05 [95% CI 0.81, 1.36]). Analyses according to BMI categories corroborated these findings. Effect modification was not evident by sex, smoking status or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62 [95% CI 0.47, 0.80]), kidney disease (HR 0.57 [95% CI 0.40, 0.81]) and neuropathy (HR 0.73 [95% CI 0.52, 1.03]), compared with participants with a stable BMI; no clear association was observed for macrovascular complications (HR 1.04 [95% CI 0.62, 1.74]). The associations between BMI gain compared with stable BMI and diabetes-related vascular complications were less apparent. Associations were consistent across strata of sex, age, pre-diagnosis BMI or medication but appeared to be stronger among never-smokers compared with current or former smokers. Conclusions/interpretation Among people with incident type 2 diabetes, pre-diagnosis BMI was positively associated with microvascular complications, while a reduced risk was observed with weight loss when compared with stable weight. The relationships with macrovascular disease were less clear. Graphical abstract Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type 2 diabetes remains unresolved. We investigated the association between BMI and BMI change with long-term risk of microvascular and macrovascular complications in type 2 diabetes in a prospective cohort study. We studied participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort, who were free of cancer, cardiovascular disease and microvascular disease at diagnosis (n = 1083). Pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI were evaluated in multivariable-adjusted Cox models. There were 85 macrovascular (myocardial infarction and stroke) and 347 microvascular events (kidney disease, neuropathy and retinopathy) over a median follow-up of 10.8 years. Median pre-diagnosis BMI was 29.9 kg/m (IQR 27.4-33.2), and the median relative annual BMI change was -0.4% (IQR -2.1 to 0.9). Higher pre-diagnosis BMI was positively associated with total microvascular complications (multivariable-adjusted HR per 5 kg/m [95% CI]: 1.21 [1.07, 1.36], kidney disease 1.39 [1.21, 1.60] and neuropathy 1.12 [0.96, 1.31]) but not with macrovascular complications (HR 1.05 [95% CI 0.81, 1.36]). Analyses according to BMI categories corroborated these findings. Effect modification was not evident by sex, smoking status or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62 [95% CI 0.47, 0.80]), kidney disease (HR 0.57 [95% CI 0.40, 0.81]) and neuropathy (HR 0.73 [95% CI 0.52, 1.03]), compared with participants with a stable BMI; no clear association was observed for macrovascular complications (HR 1.04 [95% CI 0.62, 1.74]). The associations between BMI gain compared with stable BMI and diabetes-related vascular complications were less apparent. Associations were consistent across strata of sex, age, pre-diagnosis BMI or medication but appeared to be stronger among never-smokers compared with current or former smokers. Among people with incident type 2 diabetes, pre-diagnosis BMI was positively associated with microvascular complications, while a reduced risk was observed with weight loss when compared with stable weight. The relationships with macrovascular disease were less clear. |
| Author | Polemiti, Elli Schulze, Matthias B. Jäger, Susanne Baudry, Julia Bergmann, Manuela M. Weikert, Cornelia Kuxhaus, Olga |
| Author_xml | – sequence: 1 givenname: Elli orcidid: 0000-0001-9526-3468 surname: Polemiti fullname: Polemiti, Elli organization: Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), German Center for Diabetes Research (DZD) – sequence: 2 givenname: Julia orcidid: 0000-0002-7919-6039 surname: Baudry fullname: Baudry, Julia organization: Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), German Center for Diabetes Research (DZD) – sequence: 3 givenname: Olga surname: Kuxhaus fullname: Kuxhaus, Olga organization: Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), German Center for Diabetes Research (DZD) – sequence: 4 givenname: Susanne orcidid: 0000-0001-6619-0861 surname: Jäger fullname: Jäger, Susanne organization: Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), German Center for Diabetes Research (DZD) – sequence: 5 givenname: Manuela M. orcidid: 0000-0001-5064-227X surname: Bergmann fullname: Bergmann, Manuela M. organization: Human Study Center, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) – sequence: 6 givenname: Cornelia orcidid: 0000-0003-1756-0146 surname: Weikert fullname: Weikert, Cornelia organization: German Federal Institute for Risk Assessment, Department of Food Safety – sequence: 7 givenname: Matthias B. surname: Schulze fullname: Schulze, Matthias B. email: mschulze@dife.de organization: Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), German Center for Diabetes Research (DZD), Institute of Nutritional Science, University of Potsdam |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33452586$$D View this record in MEDLINE/PubMed https://hal.science/hal-03174524$$DView record in HAL |
| BookMark | eNp9ks9uEzEQxi1URNPCC3BAlrjAYcH_7eWAVKJCIwXRQw_cLK_Xm7js2mG9G5Qn4LXxJi2UHHoaaeb3jWfG3xk4CTE4AF5i9A4jJN8nhDDhBSKoQJwKUsgnYIYZJQViRJ2A2VQvsBLfT8FZSrcIIcqZeAZOKWWccCVm4PenrwtoQg2naNcmrBxsYtvGXz6soA_W1y4McNhtHCSw9qZyg0t7Re_TDxgb2Hnbx61JdmxNv6905mHGxm7TemsGH0P6AIe1g5fXi3lxHYdUmw6mYax3z8HTxrTJvbiL5-Dm8-XN_KpYfvuymF8sC8slGwqmasMQNqxqFFVKOuEMEbhxFXJIWosooZUpOW94RYQRmaEUM8Nq0ThU0XPw8dB2M1adq23erTet3vS-M_1OR-P1_5Xg13oVt1qWDBFBc4O3hwbrI9nVxVJPOUSxzMdlW5zZN3eP9fHn6NKgO5-sa1sTXByTJkwqXrJSyoy-PkJv49iHfIlMlUqWipUkU68eTv_3_fvvzIA6APn-KfWu0dYP-8PnZXyrMdKTc_TBOTo7R--do6cJyJH0vvujInoQpQxn6_T_xn5E9Qf-QtXT |
| CitedBy_id | crossref_primary_10_1016_j_jdiacomp_2025_109091 crossref_primary_10_1038_s44220_023_00158_1 crossref_primary_10_4093_dmj_2022_0159 crossref_primary_10_1016_j_numecd_2024_05_001 crossref_primary_10_3389_fendo_2023_1131395 crossref_primary_10_1186_s12933_021_01326_2 crossref_primary_10_1007_s13300_024_01536_3 crossref_primary_10_1210_clinem_dgac485 crossref_primary_10_1016_j_jad_2025_119436 crossref_primary_10_71079_ASIDE_IM_081825136 crossref_primary_10_1016_j_diabres_2022_109805 crossref_primary_10_1007_s40265_023_01852_1 crossref_primary_10_3390_ijerph18073659 crossref_primary_10_1186_s12933_022_01460_5 crossref_primary_10_1111_dom_16196 crossref_primary_10_1177_19322968211035375 crossref_primary_10_1186_s12933_022_01670_x crossref_primary_10_1016_j_diabres_2023_110975 crossref_primary_10_1016_j_pcd_2022_03_009 crossref_primary_10_1038_s41598_022_22495_4 crossref_primary_10_1161_JAHA_122_027558 crossref_primary_10_12677_jcpm_2025_42161 crossref_primary_10_1016_j_cpcardiol_2023_101726 crossref_primary_10_1186_s12933_021_01439_8 crossref_primary_10_1155_2022_4914791 crossref_primary_10_1111_joim_13673 crossref_primary_10_1080_14767058_2024_2316732 crossref_primary_10_1371_journal_pone_0312374 crossref_primary_10_1111_dom_15598 crossref_primary_10_1111_dom_16620 crossref_primary_10_3389_fgene_2022_872962 crossref_primary_10_1111_dom_15772 crossref_primary_10_1038_s41598_021_01976_y crossref_primary_10_1016_j_jdiacomp_2022_108234 crossref_primary_10_1080_0886022X_2024_2417738 crossref_primary_10_2147_CLEP_S450455 crossref_primary_10_1186_s12933_022_01503_x crossref_primary_10_3390_nu13124482 crossref_primary_10_1016_j_jdiacomp_2022_108259 crossref_primary_10_1186_s12933_025_02861_y crossref_primary_10_1007_s00125_025_06482_8 crossref_primary_10_3389_fendo_2023_1278665 crossref_primary_10_1016_S0140_6736_21_01919_X crossref_primary_10_4102_phcfm_v16i1_4608 crossref_primary_10_1016_j_jdiacomp_2024_108813 crossref_primary_10_1080_0886022X_2025_2468741 crossref_primary_10_1111_dom_16461 crossref_primary_10_3389_fendo_2022_815390 |
| Cites_doi | 10.5301/jn.5000062 10.1093/ajcn/70.4.439 10.1007/s00592-018-1219-7 10.1007/s11428-019-0459-7 10.1016/S2213-8587(16)30162-0 10.2337/dc20-S008 10.1097/MD.0000000000000041 10.1111/1753-0407.12514 10.1007/s00125-016-4162-6 10.1007/s12020-019-01892-2 10.1016/j.diabres.2019.107807 10.2337/dc18-1842 10.1002/sim.4067 10.1159/000012788 10.1177/1559827616650415 10.1007/s00125-019-4886-1 10.2307/2290085 10.1186/s12916-018-1082-y 10.1056/NEJMoa1304501 10.1002/dmrr.2574 10.1159/000012787 10.1016/S0140-6736(17)33102-1 10.1161/JAHA.118.010512 10.1007/s00125-008-1190-x 10.7326/m14-1551 10.1016/j.jand.2015.02.031 10.1111/jdi.12677 10.1161/Strokeaha.114.006718 10.1371/journal.pone.0146889 10.1016/j.numecd.2009.02.013 10.1038/s41598-017-07438-8 10.3389/fneur.2019.00563 10.1056/NEJMoa1212914 10.1111/dom.12217 10.14423/SMJ.0000000000000214 10.1159/000012789 10.1111/jgs.13058 10.1136/bmjopen-2015-010836 10.2337/dc06-0224 10.1001/archinte.157.6.650 10.1016/j.jdiacomp.2016.02.020 10.1111/dom.13813 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 1XC 5PM |
| DOI | 10.1007/s00125-020-05362-7 |
| DatabaseName | Springer Nature OA/Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-0428 |
| EndPage | 825 |
| ExternalDocumentID | PMC7940263 oai:HAL:hal-03174524v1 33452586 10_1007_s00125_020_05362_7 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Observational Study |
| GeographicLocations | Germany |
| GeographicLocations_xml | – name: Germany |
| GrantInformation_xml | – fundername: German Cancer Aid grantid: Grant 70-2488-Ha I – fundername: European Community grantid: SOC 98200769 05 F02 – fundername: Federal Ministry of Science, Germany grantid: 01 EA 9401 – fundername: German Federal Ministry of Education and Research (BMBF) – fundername: European Union grantid: SOC 95201408 05 F02 – fundername: ; – fundername: ; grantid: 01 EA 9401 – fundername: ; grantid: SOC 98200769 05 F02 – fundername: ; grantid: SOC 95201408 05 F02 – fundername: ; grantid: Grant 70-2488-Ha I |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .GJ .VR 06C 06D 0R~ 0VY 199 1CY 1N0 1SB 2.D 203 28- 29F 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7X7 88E 8AO 8C1 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAEWM AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFDYV AFEXP AFFNX AFJLC AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z J5H JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- MVM N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P6G P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOK QOR QOS R4E R89 R9I RHV RIG ROL RPX RRX RSV S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TR2 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WH7 WJK WK8 X7M YLTOR Z45 Z7U Z7V Z7W Z82 Z83 Z87 Z8O Z8P Z8Q Z8V Z8W Z91 Z92 ZGI ZMTXR ZOVNA ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7T5 7XB 8FK H94 K9. PKEHL PQEST PQUKI 7X8 ESTFP 1XC 5PM |
| ID | FETCH-LOGICAL-c574t-48da401a4bf83887e6ea261feb0e07cc0323ba955f5b26a63883314a4d6fe0b3 |
| IEDL.DBID | 8C1 |
| ISICitedReferencesCount | 56 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000607982500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0012-186X 1432-0428 |
| IngestDate | Tue Nov 04 01:58:41 EST 2025 Tue Oct 14 20:27:06 EDT 2025 Sun Nov 09 12:12:22 EST 2025 Thu Nov 27 13:42:23 EST 2025 Mon Jul 21 06:02:24 EDT 2025 Sat Nov 29 02:07:43 EST 2025 Tue Nov 18 22:18:25 EST 2025 Fri Feb 21 02:48:59 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | CVD Nephropathy Weight change T2D Diabetes-related vascular complications Neuropathy BMI |
| Language | English |
| License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c574t-48da401a4bf83887e6ea261feb0e07cc0323ba955f5b26a63883314a4d6fe0b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 PMCID: PMC7940263 |
| ORCID | 0000-0002-7919-6039 0000-0003-1756-0146 0000-0001-9526-3468 0000-0001-5064-227X 0000-0001-6619-0861 0000-0002-0830-5277 |
| OpenAccessLink | https://link.springer.com/10.1007/s00125-020-05362-7 |
| PMID | 33452586 |
| PQID | 2498798492 |
| PQPubID | 48469 |
| PageCount | 12 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7940263 hal_primary_oai_HAL_hal_03174524v1 proquest_miscellaneous_2478594977 proquest_journals_2498798492 pubmed_primary_33452586 crossref_citationtrail_10_1007_s00125_020_05362_7 crossref_primary_10_1007_s00125_020_05362_7 springer_journals_10_1007_s00125_020_05362_7 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-04-01 |
| PublicationDateYYYYMMDD | 2021-04-01 |
| PublicationDate_xml | – month: 04 year: 2021 text: 2021-04-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationSubtitle | Clinical, Translational and Experimental Diabetes and Metabolism |
| PublicationTitle | Diabetologia |
| PublicationTitleAbbrev | Diabetologia |
| PublicationTitleAlternate | Diabetologia |
| PublicationYear | 2021 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V Springer Verlag |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V – name: Springer Verlag |
| References | Thomas, Khunti, Curcin (CR7) 2014; 16 Eeg-Olofsson, Cederholm, Nilsson (CR10) 2009; 52 Lean, Leslie, Barnes (CR22) 2018; 391 Gregg, Jakicic, Lewis (CR25) 2016; 4 Li, Katzmarzyk, Horswell (CR4) 2015; 46 Park, Lee, Yoo (CR6) 2019; 10 Costanzo, Cleland, Pellicori (CR9) 2015; 162 CR39 Landgraf, Kellerer, Aberle (CR45) 2019; 15 CR16 Rubin (CR38) 2004 Mohsen, Brown, Hoefield (CR21) 2012; 25 Xing, Pei, Huang, Peng, Chen, Hu (CR8) 2018; 7 Rossi, Nicolucci, Pellegrini (CR13) 2010; 20 Hamasaki, Kawashima, Katsuyama, Sako, Goto, Yanai (CR42) 2017; 7 Gray, Picone, Sloan, Yashkin (CR11) 2015; 108 Franz, Boucher, Rutten-Ramos, VanWormer (CR23) 2015; 115 Galbete, Kröger, Jannasch (CR34) 2018; 16 (CR43) 2020; 43 Owusu Adjah, Ray, Paul (CR5) 2019; 56 Schlesinger, Herder, Kannenberg (CR14) 2019; 42 Tobias, Manson (CR3) 2018; 12 Svensson, Tyrberg, Nystrom (CR15) 2015; 31 Chung, Al Mamun, Huang (CR19) 2017; 9 Klein, Klein, Moss (CR20) 1997; 157 Kroke, Bergmann, Lotze, Jeckel, Klipstein-Grobusch, Boeing (CR32) 1999; 43 Bergmann, Bussas, Boeing (CR31) 1999; 43 Xing, Pei, Huang (CR40) 2019; 64 (CR36) 2000; 894 Lin, Wei (CR37) 1989; 84 Huang, Chen, Lin, Lin-Tan, Hsu, Yen (CR18) 2014; 93 CR28 Strelitz, Ahern, Long (CR26) 2019; 62 Kroke, Klipstein-Grobusch, Voss (CR33) 1999; 70 White, Royston, Wood (CR35) 2011; 30 Aucott, Philip, Avenell (CR44) 2016; 6 Køster-Rasmussen, Simonsen, Siersma, Henriksen, Heitmann, Olivarius (CR27) 2016; 11 Bentata, Abouqal (CR17) 2014; 62 Zaccardi, Dhalwani, Papamargaritis (CR1) 2017; 60 Boeing, Korfmann, Bergmann (CR30) 1999; 43 Tobias, Pan, Jackson (CR41) 2014; 370 Nakanishi, Hirukawa, Shimoda (CR12) 2019; 155 (CR24) 2013; 369 Gao, Wang, Shen, Yang, Nie, Zhou (CR2) 2018; 9 Smith, Russell, Feldman (CR29) 2006; 29 R Klein (5362_CR20) 1997; 157 MM Bergmann (5362_CR31) 1999; 43 ZH Xing (5362_CR8) 2018; 7 K Eeg-Olofsson (5362_CR10) 2009; 52 A Kroke (5362_CR32) 1999; 43 EW Gregg (5362_CR25) 2016; 4 Z Xing (5362_CR40) 2019; 64 MJ Franz (5362_CR23) 2015; 115 Look AHEAD Research Group (5362_CR24) 2013; 369 H Boeing (5362_CR30) 1999; 43 C Galbete (5362_CR34) 2018; 16 IR White (5362_CR35) 2011; 30 R Landgraf (5362_CR45) 2019; 15 H Park (5362_CR6) 2019; 10 DY Lin (5362_CR37) 1989; 84 N Gray (5362_CR11) 2015; 108 R Køster-Rasmussen (5362_CR27) 2016; 11 J Strelitz (5362_CR26) 2019; 62 A Kroke (5362_CR33) 1999; 70 F Gao (5362_CR2) 2018; 9 S Nakanishi (5362_CR12) 2019; 155 Y Bentata (5362_CR17) 2014; 62 P Costanzo (5362_CR9) 2015; 162 5362_CR16 World Health Organization (5362_CR36) 2000; 894 A Mohsen (5362_CR21) 2012; 25 5362_CR39 H Hamasaki (5362_CR42) 2017; 7 American Diabetes Association (5362_CR43) 2020; 43 G Thomas (5362_CR7) 2014; 16 WH Huang (5362_CR18) 2014; 93 MK Svensson (5362_CR15) 2015; 31 MC Rossi (5362_CR13) 2010; 20 LS Aucott (5362_CR44) 2016; 6 HF Chung (5362_CR19) 2017; 9 DK Tobias (5362_CR41) 2014; 370 DK Tobias (5362_CR3) 2018; 12 WQ Li (5362_CR4) 2015; 46 S Schlesinger (5362_CR14) 2019; 42 ME Lean (5362_CR22) 2018; 391 ES Owusu Adjah (5362_CR5) 2019; 56 F Zaccardi (5362_CR1) 2017; 60 5362_CR28 DB Rubin (5362_CR38) 2004 AG Smith (5362_CR29) 2006; 29 |
| References_xml | – volume: 25 start-page: 384 issue: 3 year: 2012 end-page: 393 ident: CR21 article-title: Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus publication-title: J Nephrol doi: 10.5301/jn.5000062 – volume: 70 start-page: 439 issue: 4 year: 1999 end-page: 447 ident: CR33 article-title: Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods publication-title: Am J Clin Nutr doi: 10.1093/ajcn/70.4.439 – volume: 56 start-page: 87 issue: 1 year: 2019 end-page: 96 ident: CR5 article-title: Ethnicity-specific association of BMI levels at diagnosis of type 2 diabetes with cardiovascular disease and all-cause mortality risk publication-title: Acta Diabetol doi: 10.1007/s00592-018-1219-7 – volume: 15 start-page: 146 issue: 2 year: 2019 end-page: 167 ident: CR45 article-title: Therapie des Typ-2-Diabetes publication-title: Diabetologe doi: 10.1007/s11428-019-0459-7 – volume: 4 start-page: 913 issue: 11 year: 2016 end-page: 921 ident: CR25 article-title: Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(16)30162-0 – ident: CR39 – ident: CR16 – volume: 43 start-page: S89 issue: Suppl 1 year: 2020 end-page: S97 ident: CR43 article-title: 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2020 publication-title: Diabetes Care doi: 10.2337/dc20-S008 – volume: 93 start-page: e41 issue: 7 year: 2014 ident: CR18 article-title: High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000000041 – volume: 894 start-page: i year: 2000 end-page: xii ident: CR36 article-title: Obesity: preventing and managing the global epidemic. Report of a WHO consultation publication-title: World Health Organ Tech Rep Ser – volume: 9 start-page: 983 issue: 11 year: 2017 end-page: 993 ident: CR19 article-title: Obesity, weight change, and chronic kidney disease in patients with type 2 diabetes mellitus: a longitudinal study in Taiwan publication-title: J Diabetes doi: 10.1111/1753-0407.12514 – volume: 60 start-page: 240 issue: 2 year: 2017 end-page: 248 ident: CR1 article-title: Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies publication-title: Diabetologia doi: 10.1007/s00125-016-4162-6 – volume: 64 start-page: 82 issue: 1 year: 2019 end-page: 89 ident: CR40 article-title: Weight change is associated with increased all-cause mortality and non-cardiac mortality among patients with type 2 diabetes mellitus publication-title: Endocrine doi: 10.1007/s12020-019-01892-2 – volume: 155 start-page: 107807 year: 2019 ident: CR12 article-title: Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: a retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2019.107807 – volume: 42 start-page: 240 issue: 2 year: 2019 end-page: 247 ident: CR14 article-title: General and abdominal obesity and incident distal sensorimotor polyneuropathy: insights into inflammatory biomarkers as potential mediators in the KORA F4/FF4 cohort publication-title: Diabetes Care doi: 10.2337/dc18-1842 – volume: 30 start-page: 377 issue: 4 year: 2011 end-page: 399 ident: CR35 article-title: Multiple imputation using chained equations: issues and guidance for practice publication-title: Stat Med doi: 10.1002/sim.4067 – volume: 43 start-page: 216 issue: 4 year: 1999 end-page: 224 ident: CR32 article-title: Measures of quality control in the German component of the EPIC study. European Prospective Investigation into Cancer and Nutrition publication-title: Ann Nutr Metab doi: 10.1159/000012788 – volume: 12 start-page: 244 issue: 3 year: 2018 end-page: 251 ident: CR3 article-title: The obesity paradox in type 2 diabetes and mortality publication-title: Am J Lifestyle Med doi: 10.1177/1559827616650415 – volume: 62 start-page: 1391 issue: 8 year: 2019 end-page: 1402 ident: CR26 article-title: Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality publication-title: Diabetologia doi: 10.1007/s00125-019-4886-1 – volume: 84 start-page: 1074 issue: 408 year: 1989 end-page: 1078 ident: CR37 article-title: The robust inference for the cox proportional hazards model publication-title: J Am Stat Assoc doi: 10.2307/2290085 – volume: 16 start-page: 99 issue: 1 year: 2018 ident: CR34 article-title: Nordic diet, Mediterranean diet, and the risk of chronic diseases: the EPIC-Potsdam study publication-title: BMC Med doi: 10.1186/s12916-018-1082-y – volume: 370 start-page: 233 issue: 3 year: 2014 end-page: 244 ident: CR41 article-title: Body-mass index and mortality among adults with incident type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1304501 – volume: 31 start-page: 138 issue: 2 year: 2015 end-page: 146 ident: CR15 article-title: The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.2574 – volume: 43 start-page: 205 issue: 4 year: 1999 end-page: 215 ident: CR30 article-title: Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition publication-title: Ann Nutr Metab doi: 10.1159/000012787 – volume: 391 start-page: 541 issue: 10120 year: 2018 end-page: 551 ident: CR22 article-title: Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(17)33102-1 – volume: 7 start-page: e010512 issue: 22 year: 2018 ident: CR8 article-title: Relationship of obesity to adverse events among patients with mean 10-year history of type 2 diabetes mellitus: results of the ACCORD study publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.010512 – volume: 52 start-page: 65 issue: 1 year: 2009 end-page: 73 ident: CR10 article-title: Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients publication-title: Diabetologia doi: 10.1007/s00125-008-1190-x – volume: 162 start-page: 610 issue: 9 year: 2015 end-page: 618 ident: CR9 article-title: The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study publication-title: Ann Intern Med doi: 10.7326/m14-1551 – year: 2004 ident: CR38 publication-title: Multiple imputation for nonresponse in surveys – volume: 115 start-page: 1447 issue: 9 year: 2015 end-page: 1463 ident: CR23 article-title: Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials publication-title: J Acad Nutr Diet doi: 10.1016/j.jand.2015.02.031 – volume: 9 start-page: 44 issue: 1 year: 2018 end-page: 54 ident: CR2 article-title: Impact of obesity on mortality in patients with diabetes: meta-analysis of 20 studies including 250,016 patients publication-title: J Diabetes Investig doi: 10.1111/jdi.12677 – volume: 46 start-page: 164 issue: 1 year: 2015 end-page: 169 ident: CR4 article-title: Body mass index and stroke risk among patients with type 2 diabetes mellitus publication-title: Stroke doi: 10.1161/Strokeaha.114.006718 – volume: 11 start-page: e014688 issue: 1 year: 2016 ident: CR27 article-title: Intentional weight loss and longevity in overweight patients with type 2 diabetes: a population-based cohort study publication-title: PLoS One doi: 10.1371/journal.pone.0146889 – volume: 20 start-page: 110 issue: 2 year: 2010 end-page: 116 ident: CR13 article-title: Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2009.02.013 – volume: 7 start-page: 1 issue: 1 year: 2017 end-page: 9 ident: CR42 article-title: Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes publication-title: Sci Rep doi: 10.1038/s41598-017-07438-8 – volume: 10 start-page: 563 year: 2019 ident: CR6 article-title: Body mass index and prognosis in ischemic stroke patients with type 2 diabetes mellitus publication-title: Front Neurol doi: 10.3389/fneur.2019.00563 – volume: 369 start-page: 145 issue: 2 year: 2013 end-page: 154 ident: CR24 article-title: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes publication-title: N Engl J Med doi: 10.1056/NEJMoa1212914 – volume: 16 start-page: 317 issue: 4 year: 2014 end-page: 325 ident: CR7 article-title: Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease publication-title: Diab Obes Metab doi: 10.1111/dom.12217 – volume: 108 start-page: 29 issue: 1 year: 2015 end-page: 36 ident: CR11 article-title: The relationship between BMI and onset of diabetes mellitus and its complications publication-title: South Med J doi: 10.14423/SMJ.0000000000000214 – volume: 43 start-page: 225 issue: 4 year: 1999 end-page: 234 ident: CR31 article-title: Follow-up procedures in EPIC-Germany--data quality aspects. European Prospective Investigation into Cancer and Nutrition publication-title: Ann Nutr Metab doi: 10.1159/000012789 – volume: 62 start-page: 2002 issue: 10 year: 2014 end-page: 2004 ident: CR17 article-title: Paradoxical association between body mass index, renal progression, and cardiovascular disease in elderly adults with type 2 diabetes mellitus publication-title: J Am Geriatr Soc doi: 10.1111/jgs.13058 – volume: 6 start-page: e010836 issue: 7 year: 2016 ident: CR44 article-title: Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study publication-title: BMJ Open doi: 10.1136/bmjopen-2015-010836 – ident: CR28 – volume: 29 start-page: 1294 issue: 6 year: 2006 end-page: 1299 ident: CR29 article-title: Lifestyle intervention for pre-diabetic neuropathy publication-title: Diabetes Care doi: 10.2337/dc06-0224 – volume: 157 start-page: 650 issue: 6 year: 1997 end-page: 656 ident: CR20 article-title: Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin epidemiologic study of diabetic retinopathy publication-title: Arch Intern Med doi: 10.1001/archinte.157.6.650 – volume: 84 start-page: 1074 issue: 408 year: 1989 ident: 5362_CR37 publication-title: J Am Stat Assoc doi: 10.2307/2290085 – volume: 52 start-page: 65 issue: 1 year: 2009 ident: 5362_CR10 publication-title: Diabetologia doi: 10.1007/s00125-008-1190-x – volume: 42 start-page: 240 issue: 2 year: 2019 ident: 5362_CR14 publication-title: Diabetes Care doi: 10.2337/dc18-1842 – ident: 5362_CR39 – volume: 4 start-page: 913 issue: 11 year: 2016 ident: 5362_CR25 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(16)30162-0 – volume: 155 start-page: 107807 year: 2019 ident: 5362_CR12 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2019.107807 – volume: 12 start-page: 244 issue: 3 year: 2018 ident: 5362_CR3 publication-title: Am J Lifestyle Med doi: 10.1177/1559827616650415 – volume: 93 start-page: e41 issue: 7 year: 2014 ident: 5362_CR18 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000000041 – volume: 9 start-page: 44 issue: 1 year: 2018 ident: 5362_CR2 publication-title: J Diabetes Investig doi: 10.1111/jdi.12677 – volume: 43 start-page: S89 issue: Suppl 1 year: 2020 ident: 5362_CR43 publication-title: Diabetes Care doi: 10.2337/dc20-S008 – volume: 46 start-page: 164 issue: 1 year: 2015 ident: 5362_CR4 publication-title: Stroke doi: 10.1161/Strokeaha.114.006718 – volume: 7 start-page: e010512 issue: 22 year: 2018 ident: 5362_CR8 publication-title: J Am Heart Assoc doi: 10.1161/JAHA.118.010512 – volume: 162 start-page: 610 issue: 9 year: 2015 ident: 5362_CR9 publication-title: Ann Intern Med doi: 10.7326/m14-1551 – volume: 15 start-page: 146 issue: 2 year: 2019 ident: 5362_CR45 publication-title: Diabetologe doi: 10.1007/s11428-019-0459-7 – volume: 391 start-page: 541 issue: 10120 year: 2018 ident: 5362_CR22 publication-title: Lancet doi: 10.1016/S0140-6736(17)33102-1 – volume: 16 start-page: 317 issue: 4 year: 2014 ident: 5362_CR7 publication-title: Diab Obes Metab doi: 10.1111/dom.12217 – volume: 115 start-page: 1447 issue: 9 year: 2015 ident: 5362_CR23 publication-title: J Acad Nutr Diet doi: 10.1016/j.jand.2015.02.031 – volume: 56 start-page: 87 issue: 1 year: 2019 ident: 5362_CR5 publication-title: Acta Diabetol doi: 10.1007/s00592-018-1219-7 – volume: 31 start-page: 138 issue: 2 year: 2015 ident: 5362_CR15 publication-title: Diabetes Metab Res Rev doi: 10.1002/dmrr.2574 – ident: 5362_CR16 doi: 10.1016/j.jdiacomp.2016.02.020 – volume: 16 start-page: 99 issue: 1 year: 2018 ident: 5362_CR34 publication-title: BMC Med doi: 10.1186/s12916-018-1082-y – volume-title: Multiple imputation for nonresponse in surveys year: 2004 ident: 5362_CR38 – volume: 20 start-page: 110 issue: 2 year: 2010 ident: 5362_CR13 publication-title: Nutr Metab Cardiovasc Dis doi: 10.1016/j.numecd.2009.02.013 – volume: 62 start-page: 2002 issue: 10 year: 2014 ident: 5362_CR17 publication-title: J Am Geriatr Soc doi: 10.1111/jgs.13058 – volume: 60 start-page: 240 issue: 2 year: 2017 ident: 5362_CR1 publication-title: Diabetologia doi: 10.1007/s00125-016-4162-6 – volume: 108 start-page: 29 issue: 1 year: 2015 ident: 5362_CR11 publication-title: South Med J doi: 10.14423/SMJ.0000000000000214 – volume: 11 start-page: e014688 issue: 1 year: 2016 ident: 5362_CR27 publication-title: PLoS One doi: 10.1371/journal.pone.0146889 – volume: 64 start-page: 82 issue: 1 year: 2019 ident: 5362_CR40 publication-title: Endocrine doi: 10.1007/s12020-019-01892-2 – volume: 10 start-page: 563 year: 2019 ident: 5362_CR6 publication-title: Front Neurol doi: 10.3389/fneur.2019.00563 – volume: 9 start-page: 983 issue: 11 year: 2017 ident: 5362_CR19 publication-title: J Diabetes doi: 10.1111/1753-0407.12514 – ident: 5362_CR28 doi: 10.1111/dom.13813 – volume: 43 start-page: 205 issue: 4 year: 1999 ident: 5362_CR30 publication-title: Ann Nutr Metab doi: 10.1159/000012787 – volume: 370 start-page: 233 issue: 3 year: 2014 ident: 5362_CR41 publication-title: N Engl J Med doi: 10.1056/NEJMoa1304501 – volume: 7 start-page: 1 issue: 1 year: 2017 ident: 5362_CR42 publication-title: Sci Rep doi: 10.1038/s41598-017-07438-8 – volume: 6 start-page: e010836 issue: 7 year: 2016 ident: 5362_CR44 publication-title: BMJ Open doi: 10.1136/bmjopen-2015-010836 – volume: 369 start-page: 145 issue: 2 year: 2013 ident: 5362_CR24 publication-title: N Engl J Med doi: 10.1056/NEJMoa1212914 – volume: 43 start-page: 225 issue: 4 year: 1999 ident: 5362_CR31 publication-title: Ann Nutr Metab doi: 10.1159/000012789 – volume: 30 start-page: 377 issue: 4 year: 2011 ident: 5362_CR35 publication-title: Stat Med doi: 10.1002/sim.4067 – volume: 894 start-page: i year: 2000 ident: 5362_CR36 publication-title: World Health Organ Tech Rep Ser – volume: 157 start-page: 650 issue: 6 year: 1997 ident: 5362_CR20 publication-title: Arch Intern Med doi: 10.1001/archinte.157.6.650 – volume: 62 start-page: 1391 issue: 8 year: 2019 ident: 5362_CR26 publication-title: Diabetologia doi: 10.1007/s00125-019-4886-1 – volume: 70 start-page: 439 issue: 4 year: 1999 ident: 5362_CR33 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/70.4.439 – volume: 25 start-page: 384 issue: 3 year: 2012 ident: 5362_CR21 publication-title: J Nephrol doi: 10.5301/jn.5000062 – volume: 43 start-page: 216 issue: 4 year: 1999 ident: 5362_CR32 publication-title: Ann Nutr Metab doi: 10.1159/000012788 – volume: 29 start-page: 1294 issue: 6 year: 2006 ident: 5362_CR29 publication-title: Diabetes Care doi: 10.2337/dc06-0224 |
| SSID | ssj0003546 |
| Score | 2.5609646 |
| Snippet | Aims/hypothesis
Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2... Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity... Aims/hypothesisStudies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2... |
| SourceID | pubmedcentral hal proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 814 |
| SubjectTerms | Adult Body Mass Index Body weight Body weight loss Cardiovascular diseases Cerebral infarction Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - epidemiology Diabetic Angiopathies - diagnosis Diabetic Angiopathies - epidemiology Diabetic neuropathy Diagnosis Female Germany - epidemiology Health risks Human Physiology Humans Incidence Internal Medicine Kidney diseases Life Sciences Male Medicine Medicine & Public Health Metabolic Diseases Microvasculature Middle Aged Myocardial infarction Obesity Obesity - diagnosis Obesity - epidemiology Overweight Prognosis Prospective Studies Protective Factors Retinopathy Risk Assessment Risk Factors Time Factors Weight Gain Weight Loss |
| SummonAdditionalLinks | – databaseName: SpringerLink Contemporary (1997 - Present) dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9UwDLbYQIgX7pfCQAHxBpXaJs2FtzFt2qRtOoIJnbcqSVNtEqdFO2fjJ_C3sXPaQhkgwVOlxOkltR07_uwAvHbeKVu4LG1Ugw5K7VRqgtepdE7luSxy7uOpJYfq-FjP52bWJ4UtB7T7EJKMmnpMdqOVmbKJKXhLuT5qA67jcqdJHD98_DTqX96n5yB5mms571Nlfn-PyXK0cUpgyKuW5lXA5C9R07gY7d35v8-4C7d745Ntr7nlHlwL7X24edSH1x_At_dHB8y2NaPrOiWYNcgo3Vd8AqNdeUrrZbRtywo2bNvGEQRRZ13DFgTwG-CtsWdhf26ZQNjfMTQ_2e7sYCeddatlbRcslrt9CCd7uyc7-2l_UkPqSyVWqdC1RUfNCtdojmoryGDRNWuCy0KmvM94wZ01ZdmUrpAWZV5zngsratmEzPFHsNl2bXgCzKgQfO2VNF4JIYyVaFBpq_BeZe4ETyAf_lfl-yrmdJjG52qsvxwnuMIJruIEVyqBN-OYL-saHn-lfoVsMBJS-e397cOK2lABKlEW4jJPYGvgkqoX-mWFnqxWRgtTJPBy7EZxpRiMbUN3QTRKl0ag1Z3A4zVTjY_inILMWiagJuw2eZdpT3t2GkuCo1ZFZxpn5-3AdD9e68-f-vTfyJ_BrYIQPRG3tAWbq_OL8Bxu-MvV2fL8RRTC7xiAKuo priority: 102 providerName: Springer Nature |
| Title | BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study |
| URI | https://link.springer.com/article/10.1007/s00125-020-05362-7 https://www.ncbi.nlm.nih.gov/pubmed/33452586 https://www.proquest.com/docview/2498798492 https://www.proquest.com/docview/2478594977 https://hal.science/hal-03174524 https://pubmed.ncbi.nlm.nih.gov/PMC7940263 |
| Volume | 64 |
| WOSCitedRecordID | wos000607982500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1432-0428 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0003546 issn: 0012-186X databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_RDSFe-P4IjMog3iAiiZ3Y4QVtVadN2qpqTKhvke042iSajLUbfwL_NnduklIm9sJLo9pOa-fOlzvf7-4A3htrpE5MFFayQgOlNDLMnVVhZoyM4yyJufVVS47kZKJms3zaHrgtWlhlJxO9oC4bS2fkn9BMUDJXIk--XPwIqWoUeVfbEhoD2I6TSNDGVKM1xIO3gToohMNYZbM2aMaHzlEjxSaTK5gih-TGi2lwRrDImzrnTejkX_5T_1raf_i_C3oED1qFlO2uOOgx3HH1E7h33Lrcn8KvveNDpuuS0XUVJswqZJ7mJ86H0Uk9hfoyOsplCeuOcv0dBFtnTcXmBPrrIK--Z67_bNmAtX9mqJKy8fRwFE6b5aLUc-ZT4D6D0_3x6eggbKs3hDaVYhkKVWo03rQwleIoylzmNJprlTORi6S1EU-40XmaVqlJMo1yQHEeCy3KrHKR4c9hq25q9xJYLp2zpZVZbqUQItcZKllKS_ytNDaCBxB3lCtsm9mcCmx8L_qczJ7aBVK78NQuZAAf-nsuVnk9bh39DhmiH0gpuQ92jwpqQ6EoRZqI6ziAnY7QRSsIFsWaygG87btxC5NfRteuuaIxUqW5QE08gBcr9ur_inNyPKssALnBeBtz2eypz898mnCUtGhg49P52LHoelr_Xuqr21fxGu4nhOrx2KUd2FpeXrk3cNdeL88Xl0MYyJn0n2rot-IQtvfGk-kJfjv5-u03JAM5fQ |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Pb9MwFLe2gYAL_xmBAQbBCSIS24kdJIRG2dRqbdVDD71FtuNok9ZkrN0mPgGfhu_Ie27SUiZ224FTJNv5Y-f3nv38fu-ZkLfGGqmZicJSlmCgFEaGmbMqTI2RcZyymFt_aklfDodqMslGG-RXGwuDtMpWJ3pFXdQW98g_gpmgZKZExr6cfA_x1Cj0rrZHaCxgceB-XIDJNvvc-wb_9x1j-3vjTjdsThUIbSLFPBSq0GBUaGFKxUHEXOo0mBGlM5GLpLURZ9zoLEnKxLBUAz4V57HQokhLFxkOj90kNzCRHdp6qrNilPAmLgh0fhirdNLE6PhIPSzEUGj0PGOgklybBzcPkYV5eYl7man5l7vWz4L79_6z8btP7jbLbbq7kI8HZMNVD8mtQUMoeER-fh30qK4KitdFEDQtQTTqC-g-RT8EBjJT3KimjLYb1f4OJOXTuqRTpDS2hF5fM9V_lqyR9j9RWHDTvVGvE47q-azQU-oT_D4m4-sYhSdkq6or95TQTDpnCyvTzEohRKZTWEIqLeFZSWwED0jcAiW3Td52PD7kOF9mnPbgygFcuQdXLgPyfnnPySJryZWt3wD-lg0x4Xh3t59jGah8KRImzuOA7LS4yhs1N8tXoArI62U1KCj0OunK1WfYRqokE2BnBGR7geblqzhHt7pKAyLXcL72Les11dGhT4IO80jEUhidD61ErD7r3119dnUvXpHb3fGgn_d7w4Pn5A5D_pJnae2QrfnpmXtBbtrz-dHs9KWXfErya5aU31iIkN0 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtQwELbagiou_P8EChgEJ4ia2E7sICFUtl111e1qDz3sLbIdR63EJqW7bcUT8Ey8HTNOsstS0VsPnFaynWzifDP2eL6ZIeSdsUZqZqKwlCUYKIWRYeasClNjZBynLObWVy0ZytFITSbZeI386mJhkFbZ6USvqIva4hn5NpgJSmZKZGy7bGkR493-l9PvIVaQQk9rV06jgciB-3EJ5tvs82AXvvV7xvp7R739sK0wENpEinkoVKHBwNDClIqDuLnUaTApSmciF0lrI8640VmSlIlhqQasKs5joUWRli4yHG67Tm5JDh0YpN5bskt4GyME-j-MVTpp43V81B42Ylg0eqExaEmurInrx8jIvLrdvcra_Mt161fE_r3_eC7vk7vtNpzuNHLzgKy56iHZPGyJBo_Iz6-HA6qrguJvExxNSxCZ-hKmgqJ_AgOcKR5gU0a7A2x_BZL1aV3SKVIdO6Kv75nqP1tWyPyfKGzE6d540AvH9XxW6Cn1iX8fk6ObmIUnZKOqK_eM0Ew6Zwsr08xKIUSmU9haKi3hXklsBA9I3IEmt20-dywr8i1fZKL2QMsBaLkHWi4D8mFxzWmTzeTa0W8Bi4uBmIh8f2eYYxssBVIkTFzEAdnqMJa36m-WLwEWkDeLblBc6I3SlavPcYxUSSbA_gjI0wbZi7_iHN3tKg2IXMH8yrOs9lQnxz45OqwvEUthdj520rF8rH-_6vPr3-I12QQByYeD0cELcochrcmTt7bIxvzs3L0kt-3F_GR29sorAUryGxaU3x05maI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BMI+and+BMI+change+following+incident+type+2+diabetes+and+risk+of+microvascular+and+macrovascular+complications%3A+the+EPIC-Potsdam+study&rft.jtitle=Diabetologia&rft.au=Polemiti%2C+Elli&rft.au=Baudry%2C+Julia&rft.au=Kuxhaus%2C+Olga&rft.au=J%C3%A4ger%2C+Susanne&rft.date=2021-04-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0012-186X&rft.eissn=1432-0428&rft.volume=64&rft.issue=4&rft.spage=814&rft.epage=825&rft_id=info:doi/10.1007%2Fs00125-020-05362-7&rft_id=info%3Apmid%2F33452586&rft.externalDocID=PMC7940263 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-186X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-186X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-186X&client=summon |